(b)(4).Investigation is not possible: neither sample is available nor pictures of the failure.Thus the failure could not be confirmed.There are many reasons for clotting: according to clinical advisor; during an operation, clotting occurs on almost every foreign surface of cpb-components if no heparin or an alternative anticoagulation is given.If clotting occurs during cpb the balance between anticoagulation and coagulation system is disturbed.Unfortunately, it is not uniformly possible to predict how patients react to a certain dose of heparin.There.Several other than flow and no blood flow, long cpb times, onset of heparin-induced thrombocytopenia, disseminated intravascular coagulation (dic), sepsis or preexisting conditions that impact on coagulation system, organ injury, e.G.Lung, where certain substances are released.Another reason could be that the heparin dosage was too low despite a good act.It could be possible that acts at the lower end of sufficient anticoagulation and rather low blood flow.Clotting is a known phenomenon to maquet cardiopulmonary and has been thoroughly investigated in previous complaints.The cause of this failure was determined to not be attributed to a device related malfunction.This data will be handled through a designated maquet trending process.If a trend occurs, it will be escalated to quality assurance management for review and determination if further investigation is necessary.Due to this no further action will be completed at this time.
|